- Home
- TDG vs BMY Comparison
TDG vs BMY Comparison
Compare TDG & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TDG
- BMY
- Stock Information
- Founded
- TDG 1993
- BMY 1887
- Country
- TDG United States
- BMY United States
- Employees
- TDG N/A
- BMY N/A
- Industry
- TDG Military/Government/Technical
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- TDG Industrials
- BMY Health Care
- Exchange
- TDG Nasdaq
- BMY Nasdaq
- Market Cap
- TDG 81.4B
- BMY 97.6B
- IPO Year
- TDG 2006
- BMY N/A
- Fundamental
- Price
- TDG $1,441.82
- BMY $46.87
- Analyst Decision
- TDG Buy
- BMY Hold
- Analyst Count
- TDG 12
- BMY 16
- Target Price
- TDG $1,505.67
- BMY $58.33
- AVG Volume (30 Days)
- TDG 254.4K
- BMY 11.9M
- Earning Date
- TDG 08-05-2025
- BMY 07-31-2025
- Dividend Yield
- TDG 5.23%
- BMY 5.29%
- EPS Growth
- TDG 17.70
- BMY N/A
- EPS
- TDG 29.66
- BMY 2.67
- Revenue
- TDG $8,388,000,000.00
- BMY $47,636,000,000.00
- Revenue This Year
- TDG $12.87
- BMY N/A
- Revenue Next Year
- TDG $8.11
- BMY N/A
- P/E Ratio
- TDG $48.37
- BMY $17.55
- Revenue Growth
- TDG 14.84
- BMY 4.62
- 52 Week Low
- TDG $1,176.31
- BMY $39.35
- 52 Week High
- TDG $1,488.54
- BMY $63.33
- Technical
- Relative Strength Index (RSI)
- TDG 53.65
- BMY 40.79
- Support Level
- TDG $1,375.00
- BMY $46.39
- Resistance Level
- TDG $1,456.00
- BMY $50.76
- Average True Range (ATR)
- TDG 28.56
- BMY 0.98
- MACD
- TDG -4.94
- BMY -0.10
- Stochastic Oscillator
- TDG 70.34
- BMY 10.98
About TDG Transdigm Group Incorporated
TransDigm manufactures and services a broad set of specialized parts for commercial and military aircraft. The firm organizes itself in three segments: power and control, airframes, and a small non-aviation segment, which serves mostly off-road vehicles and mining equipment. It operates as an acquisitive holding company that focuses its portfolio on firms that make proprietary aerospace products with substantial aftermarket demand. TransDigm regularly employs financial leverage to amplify its operating results.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.